Short answer
agilon health, inc. (AGL) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $1.4B (down 7.3% year over year) with net income of $49M.
Q1 2026 key financials · XBRL
- Revenue
- $1.4B
- −7.3% YoY
- Net income
- $49M
- +303.9% YoY
- Operating margin
- 0.3%
- EPS (diluted)
- $2.94
Source: XBRL data from the agilon health, inc. (AGL) Q1 2026 10-Q on SEC EDGAR. USD.
agilon health, inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Headwinds: medical expenses exceeding revenue, membership reductions, payor dependence, healthcare regulation, management transition risks
Risk Factors
- New NYSE listing risk triggered by November 5, 2025 notice for average share price below $1.00
- Most material update: 1-for-25 reverse split on March 30, 2026 restored compliance on May 1, 2026
- Regulatory risk: future NYSE noncompliance could delist shares and reduce trading liquidity
- Market risk: continued share-price weakness could impair future equity financing and physician-partner recruitment
- Financial risk: delisting could reduce investor participation and access to equity capital
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other agilon health, inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.